Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Gains from Investment Securities (2021 - 2026)

Aura Biosciences filings provide 6 years of Gains from Investment Securities readings, the most recent being $46000.0 for Q1 2026.

  • Quarterly Gains from Investment Securities changed N/A to $46000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $735000.0 through Mar 2026, up 75.42% year-over-year, with the annual reading at $6.5 million for FY2025, 17.12% up from the prior year.
  • Gains from Investment Securities hit $46000.0 in Q1 2026 for Aura Biosciences, down from $194000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $6.0 million in Q2 2024 and bottomed at -$176000.0 in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $1.5 million, with a median of $546722.5 recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 106971.55% in 2022, while the deepest fall reached 2133.33% in 2022.
  • Aura Biosciences' Gains from Investment Securities stood at $105000.0 in 2022, then crashed by 267.62% to -$176000.0 in 2023, then skyrocketed by 381.25% to $495000.0 in 2024, then plummeted by 60.81% to $194000.0 in 2025, then plummeted by 76.29% to $46000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Gains from Investment Securities are $46000.0 (Q1 2026), $194000.0 (Q4 2025), and $285143.0 (Q3 2025).